Longfellow Investment Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,780
Closed -$133K 271
2025
Q2
$133K Hold
1,780
0.03% 141
2025
Q1
$157K Hold
1,780
0.04% 130
2024
Q4
$163K Sell
1,780
-113
-6% -$11.6K 0.04% 143
2024
Q3
$212K Buy
1,893
+11
+0.6% +$1.1K 0.05% 145
2024
Q2
$184K Buy
1,882
+13
+0.7% +$1.29K 0.05% 140
2024
Q1
$187K Buy
1,869
+14
+0.8% +$1.23K 0.04% 150
2023
Q4
$167K Hold
1,855
0.04% 142
2023
Q3
$142K Hold
1,855
0.04% 126
2023
Q2
$155K Buy
1,855
+75
+4% +$6.1K 0.04% 131
2023
Q1
$150K Hold
1,780
0.03% 139
2022
Q4
$145K Hold
1,780
0.03% 162
2022
Q3
$126K Hold
1,780
0.03% 194
2022
Q2
$160K Hold
1,780
0.03% 200
2022
Q1
$200K Hold
1,780
0.03% 212
2021
Q4
$216K Hold
1,780
0.04% 210
2021
Q3
$180K Hold
1,780
0.03% 236
2021
Q2
$208K Sell
1,780
-1,158
-39% -$139K 0.03% 239
2021
Q1
$324K Sell
2,938
-436
-13% -$47.3K 0.04% 276
2020
Q4
$339K Buy
+3,374
New +$313K 0.04% 222

Other funds holding EMN

Longfellow Investment Management's EMN Position: Q3 2025 in Review

Longfellow Investment Management sold out of Eastman Chemical (EMN) in Q3 2025, closing a stake of 1,780 shares — an estimated $133K sold.

Longfellow Investment Management first reported a position in EMN in Q4 2020 and held it in 19 quarters. The position peaked at $339K in Q4 2020. 663 funds tracked by Wall St. Rank hold EMN as of Q3 2025.

  • Longfellow Investment Management reported no remaining Eastman Chemical position as of Q3 2025 after selling out during the quarter.
  • Longfellow Investment Management sold 1,780 Eastman Chemical shares in Q3 2025, an estimated $133K.
  • Longfellow Investment Management first reported a position in Eastman Chemical in Q4 2020 and held it in 19 quarters.
  • Longfellow Investment Management's Eastman Chemical position peaked at $339K in Q4 2020.
  • 663 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2025.

Based on Longfellow Investment Management's 13F filing for Q3 2025, filed 12 Nov 2025.